726 related articles for article (PubMed ID: 17980738)
21. [Cerebral amyloid angiopathy with familial transthyretin-derived oculoleptomeningeal amyloidosis].
Ikeda SI
Brain Nerve; 2013 Jul; 65(7):831-42. PubMed ID: 23832986
[TBL] [Abstract][Full Text] [Related]
22. Vitreous involvement as initial presentation of hereditary transthyretin amyloidosis related to the rare TTR Ile107Met (p.Ile127Met) pathogenic variant.
Treviño-Herrera AB; Bustamante-Vargas AP; Lisker-Cervantes A; Ríos Y Valles Valles D; Villanueva-Mendoza C; González-Duarte A; Concha-Del-Río LE
Ophthalmic Genet; 2022 Jun; 43(3):413-419. PubMed ID: 35038954
[TBL] [Abstract][Full Text] [Related]
23. Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C.
Kawaji T; Ando Y; Nakamura M; Yamashita T; Wakita M; Ando E; Hirata A; Tanihara H
Ophthalmology; 2005 Dec; 112(12):2212. PubMed ID: 16225929
[TBL] [Abstract][Full Text] [Related]
24. Vitreal deposits in Val71Ala transthyretin amyloidosis.
Suan D; Booth DR; Kennedy IH; Downie J; Earls P; Gottlieb D; Stewart GJ; Lin MW
Intern Med J; 2012 Jan; 42(1):106-8. PubMed ID: 22276564
[No Abstract] [Full Text] [Related]
25. Phenotypic heterogeneity in a family with FAP due to a TTR Leu58Arg mutation: a clinicopathologic study.
Motozaki Y; Sugiyama Y; Ishida C; Komai K; Matsubara S; Yamada M
J Neurol Sci; 2007 Sep; 260(1-2):236-9. PubMed ID: 17466336
[TBL] [Abstract][Full Text] [Related]
26. Familial amyloid polyneuropathy associated with the novel transthyretin variant Arg34Gly.
Levy J; Hawkins PN; Rowczenio D; Godfrey T; Stawell R; Zamir E
Amyloid; 2012 Dec; 19(4):201-3. PubMed ID: 22973891
[TBL] [Abstract][Full Text] [Related]
27. Transthyretin amyloidosis: a new mutation associated with dementia.
Petersen RB; Goren H; Cohen M; Richardson SL; Tresser N; Lynn A; Gali M; Estes M; Gambetti P
Ann Neurol; 1997 Mar; 41(3):307-13. PubMed ID: 9066351
[TBL] [Abstract][Full Text] [Related]
28. A case of familial amyloid polyneuropathy due to Phe33Val TTR with vitreous involvement as the initial manifestation.
Kono S; Manabe Y; Tanaka T; Fujii D; Sakai Y; Narai H; Omori N; Ueda M; Ando Y; Abe K
Intern Med; 2010; 49(12):1213-6. PubMed ID: 20558946
[TBL] [Abstract][Full Text] [Related]
29. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
[TBL] [Abstract][Full Text] [Related]
30. Novel therapy for transthyretin-related ocular amyloidosis: a pilot study of retinal laser photocoagulation.
Kawaji T; Ando Y; Hara R; Tanihara H
Ophthalmology; 2010 Mar; 117(3):552-5. PubMed ID: 20045573
[TBL] [Abstract][Full Text] [Related]
31. A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy.
Kawaji T; Ando Y; Ando E; Nakamura M; Hirata A; Tanihara H
Amyloid; 2004 Dec; 11(4):257-9. PubMed ID: 15678760
[TBL] [Abstract][Full Text] [Related]
32. Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation.
Liu T; Zhang B; Jin X; Wang W; Lee J; Li J; Yuan H; Cheng X
Eye (Lond); 2014 Jan; 28(1):26-33. PubMed ID: 24113303
[TBL] [Abstract][Full Text] [Related]
33. Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thr and Leu55Arg.
Long D; Zeng J; Wu LQ; Tang LS; Wang HL; Wang H
Ophthalmic Genet; 2012 Mar; 33(1):28-33. PubMed ID: 21843040
[TBL] [Abstract][Full Text] [Related]
34. Vitreous amyloidosis in two sisters as the indication of transthyretin-related familial form of systemic amyloidosis among liver transplantation candidates.
Niemczyk R; Brydak-Godowska J; Kecik D; Wagner T; Lewandowski P; Kecik M; Zygier D; Ołdakowska-Jedynak U
Transplant Proc; 2009 Oct; 41(8):3085-7. PubMed ID: 19857683
[TBL] [Abstract][Full Text] [Related]
35. RE-INTERVENTION IN DE NOVO VITREOUS OPACITIES AFTER PARS PLANA VITRECTOMY IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY TTR VAL30METPORTUGUESE PATIENTS.
Ferreira NN; Cunha Dias DA; Afonso Carvalho RP; Pardal Monteiro Coelho MT
Retin Cases Brief Rep; 2019 Summer; 13(3):273-278. PubMed ID: 28333852
[TBL] [Abstract][Full Text] [Related]
36. Cytodiagnosis and protein typing of amyloid from a vitreous washing: initial diagnostic workup of hereditary amyloidosis.
Coppock JD; Dusenbery AC; Elghawy O; Fellenstein LA; Frierson HF; Shildkrot Y
J Am Soc Cytopathol; 2020; 9(3):173-176. PubMed ID: 32113804
[TBL] [Abstract][Full Text] [Related]
37. Familial amyloidosis in a large Spanish kindred resulting from a D38V mutation in the transthyretin gene.
Augustin S; Llige D; Andreu A; González A; Genescà J
Eur J Clin Invest; 2007 Aug; 37(8):673-8. PubMed ID: 17635579
[TBL] [Abstract][Full Text] [Related]
38. Clinical variant of familial amyloid polyneuropathy.
Quan D; Cohen JA
Muscle Nerve; 2002 Sep; 26(3):417-20. PubMed ID: 12210373
[TBL] [Abstract][Full Text] [Related]
39. Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF.
O'Hearn TM; Fawzi A; He S; Rao NA; Lim JI
Br J Ophthalmol; 2007 Dec; 91(12):1607-9. PubMed ID: 17522146
[TBL] [Abstract][Full Text] [Related]
40. Ocular Manifestations of Familial Transthyretin Amyloidosis.
Reynolds MM; Veverka KK; Gertz MA; Dispenzieri A; Zeldenrust SR; Leung N; Pulido JS
Am J Ophthalmol; 2017 Nov; 183():156-162. PubMed ID: 28911993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
